For: | Antony MA, Chowdhury A, Edem D, Raj R, Nain P, Joglekar M, Verma V, Kant R. Gut microbiome supplementation as therapy for metabolic syndrome. World J Diabetes 2023; 14(10): 1502-1513 [PMID: 37970133 DOI: 10.4239/wjd.v14.i10.1502] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i10/1502.htm |
Number | Citing Articles |
1 |
Philanathi Mabena, Thandi M. D. Fasemore, Pilani Nkomozepi. Impact of Nutraceuticals on Type 1 and Type 2 Diabetes Mellitus-Induced Micro- and Macrovasculopathies. Applied Sciences 2023; 14(1): 64 doi: 10.3390/app14010064
|
2 |
Ignacio Goyache, Deyan Yavorov-Dayliev, Fermín I. Milagro, Paula Aranaz. Caenorhabditis elegans as a Screening Model for Probiotics with Properties against Metabolic Syndrome. International Journal of Molecular Sciences 2024; 25(2): 1321 doi: 10.3390/ijms25021321
|
3 |
Amlan Jyoti Ghosh, Supriyo Ghosh, Rejuan Islam, Sagar Sarkar, Tilak Saha.
Dietary supplementation of
Lactobacillus brevis
SAD ameliorates high-fat diet-induced hyperglycemia and associated metabolic issues in Swiss albino mice
. Egyptian Journal of Basic and Applied Sciences 2024; 11(1): 148 doi: 10.1080/2314808X.2024.2324409
|
4 |
Yong-Wei Xu, Jun Tian, Yan Song, Ba-Cui Zhang, Jing Wang. Metabolic syndrome’s new therapy: Supplement the gut microbiome. World Journal of Diabetes 2024; 15(4): 793-796 doi: 10.4239/wjd.v15.i4.793
|